Entities / Entity
Cellectis.
biopharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
An investigation involving Cellectis was reported from New York City.Some support1 report
-
Cellectis filed reports with the SEC and its stock was listed on Nasdaq on September 15, 2026.Some support1 report
-
MarketBeat reported the average rating for Cellectis on August 7, 2026.Some support2 reports
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
What's reaching Cellectis
Events traced to Cellectis, step by step, newest firstAround Cellectis this week
News at the entities that move Cellectis most-
SEC StructuralCNBC reports on FED rate decisions and their impact on the Main Street economy and SEC yields.Moves Cellectis
-
MarketBeat Mentioned togetherMarketBeat released analyst recommendations for small-cap communication services companies Optimum Communications and Criteo.Moves Cellectis
-
New York City Shared contextDSM-Firmenich opens a new flagship location in Chelsea, NYC, while Housing Works participates in an Open Air event.Moves Cellectis
-
Nasdaq StructuralVMware's stock performance was tracked on the Nasdaq exchange on October 25, 2026.Moves Cellectis
Connections
The 5 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Cellectis operates as a publicly traded company whose stock listing and trading are dependent on the Nasdaq exchange infrastructure.
-
SEC Structural
Cellectis operates under the regulatory oversight of the SEC, requiring the filing of mandatory reports.
-
Nitin Jain Operational
Nitin Jain is actively involved in presenting and discussing Cellectis's clinical trial data.
-
MarketBeat Mentioned together
MarketBeat reports Cellectis's average rating.
-
New York City Shared context
Cellectis is associated with an investigation reported from New York City.